Christopher P. Smith, M.D., M.B.A., M.S.S., Associate Professor, is a Board-certified urologist specializing in male and female urinary incontinence and voiding dysfunction. Dr. Smith attended Northwestern University Medical School in Chicago and received his residency training in urology at Baylor College of Medicine. He completed his fellowship training under a National Institutes of Health (NIH) K12 Scholarship in Neurology and Female Urology at the University of Pittsburgh School of Medicine in Pennsylvania. He received his M.B.A. at the Katz School of Business, University of Pittsburgh, and his Master of Strategic Studies from the U.S. Army War College in Carlisle, Pennsylvania. Dr. Smith is an international expert on the basic and clinical aspects of botulinum toxin use within urology. He has used botulinum toxin clinically for over a decade. In addition to his extensive involvement in basic science research, Dr. Smith is a principal investigator on several clinical trials examining the effects of botulinum toxin to treat patients with overactive bladder and benign prostatic hyperplasia (BPH). In 2012 Dr. Smith was awarded a Department of Defense Grant comparing the efficacies of onabotulinumtoxinA vs. oxybutynin in SCI patients with NDO and a VA Merit Grant comparing the efficacy of onabotulinumtoxinA vs. tamsulosin in men with BPH and LUTS.